Boomerang Medical
About Boomerang Medical
Boomerang Medical is developing a bioelectric neuromodulation device, currently in FDA-approved clinical trials, to treat autoimmune diseases such as Crohn's disease and ulcerative colitis by stimulating the nervous system. This technology aims to provide a non-pharmacological treatment option for patients suffering from debilitating inflammatory bowel diseases, addressing the limitations of existing medication and surgical interventions.
```xml <problem> Current treatments for autoimmune diseases like Crohn's disease and ulcerative colitis, which include medications and surgery, often have limitations and may not provide adequate relief for all patients. Many individuals with inflammatory bowel disease (IBD) still experience disruptions to their daily life and well-being despite available therapies. </problem> <solution> Boomerang Medical is developing a bioelectronic neuromodulation device designed to offer a non-pharmacological treatment option for autoimmune diseases, specifically IBD. This implantable device uses targeted nerve stimulation to modulate the nervous system and reduce inflammation associated with Crohn's disease and ulcerative colitis. The technology has received Breakthrough Device Designation from the FDA and is currently undergoing clinical trials to evaluate its safety and efficacy in patients with mild to moderate IBD, including those who have previously undergone advanced therapies. The goal is to provide physicians with an additional tool to manage IBD, addressing the heterogeneity of the patient population and the limitations of existing biologic and pharmaceutical treatments. </solution> <features> - Implantable bioelectronic device for neuromodulation - Targeted nerve stimulation to treat Crohn's disease and ulcerative colitis - Designed for patients with mild to moderate IBD - Suitable for patients who have previously undergone advanced therapies - Currently undergoing FDA-approved clinical trials </features> <target_audience> The primary target audience includes individuals suffering from Crohn's disease and ulcerative colitis, as well as gastroenterologists and other healthcare providers specializing in the treatment of inflammatory bowel diseases. </target_audience> ```
What does Boomerang Medical do?
Boomerang Medical is developing a bioelectric neuromodulation device, currently in FDA-approved clinical trials, to treat autoimmune diseases such as Crohn's disease and ulcerative colitis by stimulating the nervous system. This technology aims to provide a non-pharmacological treatment option for patients suffering from debilitating inflammatory bowel diseases, addressing the limitations of existing medication and surgical interventions.
Where is Boomerang Medical located?
Boomerang Medical is based in Austin, United States.
When was Boomerang Medical founded?
Boomerang Medical was founded in 2021.
How much funding has Boomerang Medical raised?
Boomerang Medical has raised 15000000.
- Location
- Austin, United States
- Founded
- 2021
- Funding
- 15000000
- Employees
- 11 employees
- Major Investors
- Hatteras Venture Partners, Arboretum Ventures